LYZZ Capital
Venture capitalShanghai · Seed–Series A · 5 people tracked
Investment thesis
LYZZ Capital dedicates itself to healthcare investing across venture and private equity, backing talent, assets, and technologies on a global basis. The firm targets areas addressing unmet medical needs and large market potential, with a strong focus on China. Its team is drawn from leading pharmaceutical and biotech companies as well as Wall Street firms, combining scientific, medical, and financial expertise. With more than two decades of biotech investment experience and over fifteen years of activity in China, LYZZ invests out of both USD and RMB funds, seeking opportunities that connect global innovation with Chinese market demand.
Source: firm website, verified Aug 3, 2026.
Team · 5 people
from public directoriesWhat they invest in
from 8 of 13 portfolio companiesBiotech ×7Healthtech ×6Medical Devices ×4AgTech ×1AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Hardware ×1
HQs:United States×4China×1
Investments · 13 tracked
founders shown can be your intro pathCo-investorsAisling CapitalRiverVest Venture Partners
Alpha Biopharma (Chentai) is a pharmaceutical company developing innovative drugs from clinical research through commercialization.
BiotechHealthtech
Xian-ping LU(Founder)in
Co-investorsLAVLilly Asia VenturesVertex Ventures China
Jumpcode Genomics develops CRISPRclean, a next-generation sequencing technology that removes abundant, uninformative sequences to improve sensitivity, lower costs, and simplify workflows for researchers.
AI & Machine LearningBiotechDeep TechHealthtechSan Diego, US
David Michael Salter(Executive Officer, Director)Mike Salter(CEO/President)Eugene Chen(Director)Keith Brown(Executive Officer, Director)Joel Rotroff(Director)
BoardCourt Turner(Director)
Co-investorsArboretum Ventures
MicroTech Medical produces the Equil patch insulin pump, a tubeless wearable pump for people managing diabetes, and references the Aidex continuous glucose monitoring system (CGMS) for real-time glucose tracking.
Digital HealthHardwareMedical Devices
Co-investorsLAVLilly Asia VenturesQiming Venture Partners
Moji Bio applies genetic engineering, computational biology, and artificial intelligence to develop biomanufacturing processes that produce chemical materials and agricultural additives from sustainable feedstocks.
AgTechBiotechNew Materials
Neurelis is a neuroscience-based biopharmaceutical company that develops treatments for people living with neurological conditions such as epilepsy.
BiotechHealthtechMedical DevicesEncinitas, US
Craig C. Chambliss(Executive Officer, Director)inCraig Chambliss(Founder)in
BoardDavid F. Hale(Director)Cam Garner(Director)Yong Zhang(Director)Kevin Li(Director)in
Co-investorsOrbiMed
QpexBio develops anti-infective drugs designed to overcome multidrug resistance, improving existing drug classes and discovering new ones for use in combination with known anti-infectives against drug-resistant bacteria.
BiotechHealthtechSan Diego, US
Michael N. Dudley(Executive Officer, Director)Terry Gould(Director)Daniel Burgess(Director)
BoardCarol Gallagher(Director)Douglas Reed(Director)Kevin Li(Director)
Co-investorsHatteras Venture PartnersNew Enterprise Associates (NEA)
Allotera (formerly Wugen) develops allogeneic T-cell therapies.
BiotechHealthtechMedical DevicesSt. Louis, US
Ayman Kabakibi(Executive Officer)Cherry Thomas(Executive Officer)Kumar Srinivasan(Executive Officer, Director)Keith Vendola(Executive Officer)Daniel M Kemp(Executive Officer, Director)Matthew Cooper(Executive Officer)
Co-investorsAisling CapitalAlpha Wave GlobalBioGenerator VenturesRiverVest Venture PartnersAbingworthFidelity Investments+1 more
Portfolio news
latest coverage across their companiesWugen · bizjournals.com · Jul 10, 2026
Frequently asked questions
- How many investments has LYZZ Capital made?
- LYZZ Capital has 12 tracked investments.
- What stage does LYZZ Capital invest at?
- LYZZ Capital invests at the Seed, Series A stages.
- What sectors does LYZZ Capital focus on?
- LYZZ Capital focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is LYZZ Capital located?
- LYZZ Capital is headquartered in Shanghai, CN.
- Who does LYZZ Capital co-invest with?
- LYZZ Capital most often shares deals with LAV, Lilly Asia Ventures, OrbiMed, among 10 tracked co-investors.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.